HSDT is expected to report earnings to rise 16.67% to -7 cents per share on August 17
Q2'26
Est.
$-0.07
Q2'23
Beat
by $0.06
Q1'23
Beat
by $0.05
Q4'22
Missed
by $0.04
Q3'22
Beat
by $0.09
The last earnings report on August 10 showed earnings per share of -5 cents, beating the estimate of -11 cents. With 35.34K shares outstanding, the current market capitalization sits at 99.84M.
A.I. Advisor
published General Information
General Information
a medical technology company focused on neurological wellness
A.I.dvisor indicates that over the last year, HSDT has been loosely correlated with MLCI. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if HSDT jumps, then MLCI could also see price increases.
HSDT in +8.48% Uptrend, advancing for three consecutive days on July 02, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where HSDT advanced for three days, in of 197 cases, the price rose further within the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 67 cases where HSDT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for HSDT just turned positive on June 16, 2026. Looking at past instances where HSDT's MACD turned positive, the stock continued to rise in of 41 cases over the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 74 cases where HSDT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on July 23, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HSDT as a result. In of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HSDT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. HSDT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.505) is normal, around the industry mean (3.656). P/E Ratio (0.005) is within average values for comparable stocks, (25.924). HSDT's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.359). HSDT has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.094). P/S Ratio (7.353) is also within normal values, averaging (17.032).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HSDT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock worse than average.
